Stand-alone surgical ablation for atrial fibrillation: a novel bilateral double-port approach.

Lone atrial fibrillation (Lone AF) hybrid procedure mini-maze procedure (MMP)

Journal

Journal of thoracic disease
ISSN: 2072-1439
Titre abrégé: J Thorac Dis
Pays: China
ID NLM: 101533916

Informations de publication

Date de publication:
May 2019
Historique:
entrez: 10 7 2019
pubmed: 10 7 2019
medline: 10 7 2019
Statut: ppublish

Résumé

To explore an effective, reproducible and less invasive surgical approach for lone atrial fibrillation (AF). A modified "mini-maze" including pulmonary vein isolation (PVI), box-lesion and left atrial appendage (LAA) resection was applied for AF patients in our center from January 2016 to June 2017. A 2.5 cm thoracotomy extended with tissue retractor was made as working port in the fourth intercostal space on each anterior side of the chest. The thoracoscope was inserted in another port lateral to main port for observing. During PVI, the tip of the clamp could be adjusted to reach as superior as the roof of left atrium for transmural lesions. The floor line was made by linear ablation pen. The LAA was removed by stapler before PVI for better exposure of the roof. This modified "mini-maze" was successfully completed in 53 non-paroxysmal AF patients except 1 was converted to sternotomy due to intraoperative hemorrhage. All patients recovered uneventfully. Seven-day Holter was accessed in 3, 6 and 12 months respectively in all patients. The mean follow-up was 14 (range, 3-30) months. Sinus rhythm was achieved in 48.1%, 64.8% before discharge and 3 months after surgery respectively, Twenty-eight patients in sinus rhythm or not, underwent catheter mapping and ablation three months after the operation to conform the lesion set made by this procedure. Sinus rhythm reached 87.0% after subsequent catheter ablation without any anti-arrhythmia treatment at 12 months. All patients survived without stroke, hemorrhage and pulmonary vein stenosis. Modified "mini-maze" procedure is safe, less invasive and highly reproducible for lone AF. Sequential hybrid procedure will shape the treatment of non-paroxysmal AF.

Sections du résumé

BACKGROUND BACKGROUND
To explore an effective, reproducible and less invasive surgical approach for lone atrial fibrillation (AF).
METHODS METHODS
A modified "mini-maze" including pulmonary vein isolation (PVI), box-lesion and left atrial appendage (LAA) resection was applied for AF patients in our center from January 2016 to June 2017. A 2.5 cm thoracotomy extended with tissue retractor was made as working port in the fourth intercostal space on each anterior side of the chest. The thoracoscope was inserted in another port lateral to main port for observing. During PVI, the tip of the clamp could be adjusted to reach as superior as the roof of left atrium for transmural lesions. The floor line was made by linear ablation pen. The LAA was removed by stapler before PVI for better exposure of the roof.
RESULTS RESULTS
This modified "mini-maze" was successfully completed in 53 non-paroxysmal AF patients except 1 was converted to sternotomy due to intraoperative hemorrhage. All patients recovered uneventfully. Seven-day Holter was accessed in 3, 6 and 12 months respectively in all patients. The mean follow-up was 14 (range, 3-30) months. Sinus rhythm was achieved in 48.1%, 64.8% before discharge and 3 months after surgery respectively, Twenty-eight patients in sinus rhythm or not, underwent catheter mapping and ablation three months after the operation to conform the lesion set made by this procedure. Sinus rhythm reached 87.0% after subsequent catheter ablation without any anti-arrhythmia treatment at 12 months. All patients survived without stroke, hemorrhage and pulmonary vein stenosis.
CONCLUSIONS CONCLUSIONS
Modified "mini-maze" procedure is safe, less invasive and highly reproducible for lone AF. Sequential hybrid procedure will shape the treatment of non-paroxysmal AF.

Identifiants

pubmed: 31285892
doi: 10.21037/jtd.2019.04.98
pii: jtd-11-05-1989
pmc: PMC6588755
doi:

Types de publication

Journal Article

Langues

eng

Pagination

1989-1995

Déclaration de conflit d'intérêts

Conflicts of Interest: The authors have no conflicts of interest to declare.

Références

Am J Med. 2002 Oct 1;113(5):359-64
pubmed: 12401529
J Thorac Cardiovasc Surg. 2005 Sep;130(3):797-802
pubmed: 16153931
Ann Thorac Surg. 2007 Jun;83(6):2244-5
pubmed: 17532447
J Thorac Cardiovasc Surg. 1991 Apr;101(4):569-83
pubmed: 2008095
Circulation. 2012 Jan 3;125(1):23-30
pubmed: 22082673
J Am Coll Cardiol. 2012 Jul 3;60(1):54-61
pubmed: 22742400
Eur Heart J. 2013 Apr;34(14):1061-7
pubmed: 23321349
Ann Cardiothorac Surg. 2014 Jan;3(1):98-104
pubmed: 24516806
Europace. 2017 Jan;19(1):58-65
pubmed: 27247011
Eur Heart J. 2016 Oct 7;37(38):2893-2962
pubmed: 27567408
Circulation. 1998 Sep 8;98(10):946-52
pubmed: 9737513

Auteurs

Huiming Guo (H)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Hongkun Qing (H)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Yuyuan Zhang (Y)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Jian Liu (J)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Zhao Chen (Z)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Zhongming Cao (Z)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Jindong Xu (J)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Huanlei Huang (H)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Yumei Xue (Y)

Department of Cardiology, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Xianzhang Zhan (X)

Department of Cardiology, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Fangzhou Liu (F)

Department of Cardiology, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Shulin Wu (S)

Department of Cardiology, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Jian Zhuang (J)

Department of Cardiac Surgery, Atrial Fibrillation Center, Guangdong Cardiovascular Institute, Guangdong Provincial Key Laboratory of South China Structural Heart Disease, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou 510080, China.

Classifications MeSH